SMTI — Sanara MedTech Inc.

—
Nasdaq · Health Care · Health Care Equipment & Supplies · CIK 714256 ·
Last close
$32.73
Market Cap
$300.55M
52W High
$35.52
52W Low
$16.05
ADV30
109,380
Next earnings
2026-11-12
Sanara MedTech Inc., a medical technology company, develops, markets, and distributes surgical solutions to physicians, hospitals, clinics, and post-acute care settings in the United States. The company offers CellerateRX Surgical, a medical hydrolysate of Type I bovine collagen indicated for the management of surgical, traumatic, and partial and full-thickness wounds, as well as first and second-degree burns. It also develops BIASURGE, a no-rinse surgical solution used for wound irrigation; FORTIFY Tissue Repair Graft(FORTIFY TRG), a freeze-dried, multi-layer small intestinal submucosa extracellular matrix sheet; BiFORM, an osteoconductive, bioactive, porous implant that allows bony ingrowth across the graft site and it can be used as a strip or molded into a putty to fill a bone defect; ACTIGEN Inductive Bone Matrix, a naturally derived, differentiated allograft matrix with robust handling properties; ALLOCYTE Plus, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers; and TEXAGEN, a multi-layer amniotic membrane allograft used as an anatomical barrier with robust handling that can be sutured for securement. The company has a license agreement with Rochal to develop, market, and sell antimicrobial products that include BIASURGE Advanced Surgical Solution, BIAKOS Antimicrobial Wound Gel, and BIAKOS Antimicrobial Skin and Wound Cleanser for the prevention and treatment of microbes on the human body. Sanara MedTech Inc. was incorporated in 2001 and is based in Fort Worth, Texas.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 28,430,158 26,325,241 736,005 -1,411,547 72,235,148 16,787,737 64,569,604
Jun 2026 28,136,757 26,155,410 1,780,377 -452,864 69,146,387 15,421,170 61,211,927
Mar 2026 27,798,534 25,874,945 2,646,581 458,957 69,277,117 13,594,459 62,257,622
Dec 2025 27,545,815 25,671,309 2,891,579 -1,609,914 72,944,071 16,578,857 67,014,295

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$5,694,567
Investing CF
$-5,915,119
Financing CF
$-1,317,022
CapEx
$-1,190,694
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-3.71
As of
2026-11-15

Balance + Analyst (yfinance extras)

Retained Earnings
$-74,891,763
Inventory
$3,459,921
Receivables
$12,572,651
ST Investments
—
EBIT TTM
$6,974,522
Pretax Income TTM
$-286,274
Interest Exp TTM
$7,260,796
Analysts
3

Yahoo Snapshot (yfinance, live)

Total Revenue
$111,911,264
EBITDA
$10,542,345
Free Cash Flow
$3,634,473
Enterprise Value
$328,963,040
Total Cash
$16,787,736
Total Debt
$48,686,432
Shares Out
9,182,824
Trailing EPS
$-0.28
Book Value
$0.83
ROE
-34.9%
ROA
7.0%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 103,117,982 9,145,658 -37,562,606 72,944,071 67,014,295 5,938,442 6,786,629
Dec 2024 86,672,425 1,244,390 -9,664,547 88,091,992 49,180,030 39,403,573 -23,784
Dec 2023 64,989,842 -7,665,048 -4,303,197 73,871,149 29,283,132 44,832,277 -3,245,556
Dec 2022 45,842,845 -12,232,434 -7,937,497 61,035,386 19,315,411 41,827,530 -5,554,870

TTM Snapshot

Revenues TTM
$109,788,343
NetIncome TTM
$-32,014,974
OpCashFlow TTM
—
Assets (Latest)
$69,146,387
Forward EPS
$0.54

Peers — same industry

TickerNameMarket CapLastDaily %
INFU InfuSystem Holdings, Inc $296.30M $14.79 —
TMCI TREACE MEDICAL CONCEPTS, INC. $288.75M $4.44 —
NPCE NeuroPace Inc $282.50M $8.20 —
OFIX Orthofix Medical Inc. $271.87M $6.67 —
SSII SS Innovations International, Inc. $266.51M $1.33 —

News headlines (Yahoo Finance, 1h cache)

MiMedx Group Bets on Surgery Growth and Sanara Deal as Wound Care Struggles
2026-11-16 04:12 · Yahoo
Sanara MedTech Inc. (SMTI) Surpasses Q3 Earnings Estimates
2026-11-12 23:35 · Yahoo
Sanara MedTech Inc. Reports Third Quarter 2026 Financial Results (Unaudited)
2026-11-12 21:10 · Yahoo
Sanara MedTech Inc. (SMTI) Tops Q2 Earnings Estimates
2026-08-11 23:10 · Yahoo
MIMEDX to Acquire Sanara MedTech
2026-07-29 20:01 · Yahoo
Sanara MedTech (SMTI) Stock Gets Fair Value Bump As Analysts Back Wound Care Growth
2026-06-23 02:14 · Yahoo
How The Sanara MedTech (SMTI) Narrative Is Shifting As The US$34 Target Stays Put
2026-05-23 01:14 · Yahoo
Sanara MedTech (SMTI) Q1 2026 Earnings Transcript
2026-06-02 16:56 · Yahoo
What MiMedx Group (MDXG) Said on Its Q3 Earnings Call
2026-10-29 03:04 · Yahoo
MiMedx-Sanara Merger Faces Fresh Regulatory Obstacle – SMTI Stock Falls Below This Key Support Level For The First Time In 4 Months
2026-10-16 17:00 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.